XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating Activities    
Net loss $ (18,875) $ (17,618)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 4,233 4,677
Depreciation and amortization 4,451 4,575
Amortization of marketable securities discount 0 (114)
Other noncash expense 656 234
Changes in operating assets and liabilities:    
Accounts receivable 135 (429)
Inventories (55) 1,650
Prepaid expenses and other current assets, deposits and other assets (3,297) (2,193)
Accounts payable, accrued expenses and non-current liabilities (3,326) 446
Net cash used in operating activities (16,078) (8,772)
Investing Activities    
Acquisitions of property, plant and equipment (17,512) (22,093)
Proceeds from maturity of marketable securities 0 135,550
Proceeds from sale of property, plant and equipment 0 67
Net cash (used in) provided by investing activities (17,512) 113,524
Financing Activities    
Payment of loans payable (32) (39)
Payment of finance lease liabilities (23) (23)
Repurchases of common stock (1,397) 0
Net cash used in by financing activities (1,452) (62)
Net (decrease) increase in cash and cash equivalents (35,042) 104,690
Cash, cash equivalents and restricted cash at beginning of period 375,597 315,376
Cash, cash equivalents and restricted cash at end of period 340,555 420,066
Schedule of cash, cash equivalents and restricted cash    
Cash and cash equivalents 270,642 342,298
Restricted cash (current)   1,032
Restricted cash (non-current) 69,913 76,736
Total cash, cash equivalents and restricted cash 340,555 420,066
Supplemental disclosures of cash and non-cash investing and financing transactions    
Cash paid for interest 770 515
Non-cash purchase of property, plant and equipment 9,554 13,277
Right-of-use asset purchased with operating lease $ 35 $ 0